Holen Sie sich die Stockscreener-App
0.72
1.28%
-0.0093
Vorhandelsmarkt:
.72
Schlusskurs vom Vortag:
$0.7293
Offen:
$0.7518
24-Stunden-Volumen:
267.00K
Relative Volume:
0.30
Marktkapitalisierung:
$39.96M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.23M
KGV:
-1.2816
EPS:
-0.5618
Netto-Cashflow:
$-13.97M
1W Leistung:
+12.50%
1M Leistung:
-17.81%
6M Leistung:
-70.37%
1J Leistung:
-44.19%
1-Tages-Spanne:
$0.70
$0.7643
1-Wochen-Bereich:
$0.6342
$0.7732
52-Wochen-Spanne:
$0.54
$4.00
Heartbeam Inc Stock (BEAT) Company Profile
Firmenname
Heartbeam Inc
Sektor
Branche
Telefon
408-899-4443
Adresse
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
0.72 | 41.63M | 0 | -20.23M | -13.97M | -0.5618 |
VEEV
Veeva Systems Inc
|
192.74 | 28.83B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
69.03 | 13.69B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
60.27 | 10.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
95.31 | 7.55B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
84.05 | 6.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-20 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2026-03-31 | Eingeleitet | B. Riley Securities | Buy |
| 2026-03-27 | Eingeleitet | D. Boral Capital | Buy |
| 2026-03-16 | Herabstufung | The Benchmark Company | Buy → Speculative Buy |
| 2025-12-11 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
| 2025-12-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-10-31 | Eingeleitet | Roth Capital | Buy |
| 2020-09-11 | Eingeleitet | Needham | Buy |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-08-02 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | Bestätigt | Dougherty & Company | Buy |
| 2018-07-26 | Bestätigt | Lake Street | Buy |
| 2018-04-26 | Bestätigt | The Benchmark Company | Buy |
| 2018-02-23 | Bestätigt | Dougherty & Company | Buy |
| 2017-11-08 | Bestätigt | Dougherty & Company | Buy |
| 2017-10-26 | Eingeleitet | Raymond James | Outperform |
| 2017-10-24 | Eingeleitet | SunTrust | Buy |
| 2017-08-09 | Bestätigt | Dougherty & Company | Buy |
| 2017-07-19 | Bestätigt | The Benchmark Company | Buy |
| 2017-04-11 | Bestätigt | Dougherty & Company | Buy |
| 2016-12-02 | Eingeleitet | Dougherty & Company | Buy |
| 2016-09-13 | Eingeleitet | Sidoti | Buy |
| 2016-08-03 | Bestätigt | The Benchmark Company | Buy |
| 2015-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2013-10-24 | Eingeleitet | The Benchmark Company | Buy |
| 2013-08-21 | Eingeleitet | Dougherty & Company | Buy |
Alle ansehen
Heartbeam Inc Aktie (BEAT) Neueste Nachrichten
HeartBeam (BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital - Yahoo Finance
HeartBeam (BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study - NewMediaWire
HeartBeam (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study - USA Today
HeartBeam (BEAT) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $BEAT - MarketBeat
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study - marketscreener.com
HeartBeam completes enrollment in heart attack detection study - Investing.com
HeartBeam completes enrollment in heart attack detection study By Investing.com - Investing.com Australia
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule - Business Wire
Certain Restricted Stock Units of HeartBeam, Inc. are subject to a Lock-Up Agreement Ending on 29-JUN-2026. - marketscreener.com
Certain Warrants of HeartBeam, Inc. are subject to a Lock-Up Agreement Ending on 29-JUN-2026. - marketscreener.com
BEATW Warrants Hold at $0.03: Stalemate Persists for Heartbeam Inc. WarrantsInvestment Factor - dars.gov.et
HeartBeam (BEAT) Stock Sees Fair Value Cut As Analysts Weigh Dilution And Slower Ramp - Yahoo Finance
Price to book forward of Heartbeam, Inc. – NASDAQ:BEAT - TradingView
Enterprise value to revenue forward of Heartbeam, Inc. – NASDAQ:BEAT - TradingView
Price to sales forward of Heartbeam, Inc. – NASDAQ:BEAT - TradingView
HeartBeam (BEAT) Reorganizes to Accelerate Global Commercialization Strategy - NewMediaWire
HeartBeam Reorganizes to Accelerate Global Commercialization of Cardiac Monitoring Technology - MEXC
HeartBeam, Inc. Actuals & Estimates (NASDAQ:BEAT) - TradingView
BEAT Forecast — Price Target — Prediction for 2027 - TradingView
HeartBeam CEO Robert Eno to Step Down; Founder Branislav Vajdic to Lead Operations - Moomoo
HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition - 01net
HeartBeam restructures to license 3D ECG technology - TipRanks
HeartBeam Announces Strategic Shift to Accelerate Global Adoption - The National Law Review
Heartbeam Former CEO Robert Eno Will Transition to Consulting Role >BEAT - Moomoo
Leadership shakeup as HeartBeam (NASDAQ: BEAT) reorganizes for global ECG push - Stock Titan
HeartbeamAdvancing Toward Heart Attack Det - Moomoo
Heartbeam Announces Strategic Shift to Accele - Moomoo
Heartbeam Inc (BEAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Heartbeam Inc (BEAT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Heartbeam Inc. (BEAT) Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Operational ProgressRevenue Guidance Update - dars.gov.et
HeartBeam (BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection - TradingView
Heartbeam Inc (BEATW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
[8-K] HeartBeam, Inc. Reports Material Event - Stock Titan
BEATW | Heartbeam, Inc. Warrant Insider Trading - Quiver Quantitative
BEATW | Heartbeam, Inc. Warrant Executive Compensation - Quiver Quantitative
Heartbeam Inc (BEATW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Heartbeam Inc (BEATW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Heartbeam Inc (BEATW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BEAT News | HEARTBEAM INC (NASDAQ:BEAT) - ChartMill
HeartBeam (NASDAQ: BEAT) seeks approval for 3M-share equity plan increase at 2026 meeting - Stock Titan
Heartbeam Inc (BEAT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Heartbeam Inc (BEAT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Heartbeam Inc (BEAT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Heartbeam Inc (BEAT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Heartbeam Inc (BEAT) Institutional Confidence - TradingKey
Heartbeam Inc (BEAT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Heartbeam Inc (BEAT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Heartbeam Inc (BEATW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Heartbeam Inc (BEATW) Institutional Confidence - TradingKey
Heartbeam Inc (BEATW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Finanzdaten der Heartbeam Inc-Aktie (BEAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Heartbeam Inc-Aktie (BEAT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Elfrink Willem | Director |
Apr 16 '26 |
Buy |
0.80 |
187,500 |
150,000 |
538,667 |
| JAFF MICHAEL R | Director |
Apr 16 '26 |
Buy |
0.80 |
31,250 |
25,000 |
31,250 |
| Vajdic Branislav | Director |
Apr 16 '26 |
Buy |
0.80 |
31,250 |
25,000 |
909,914 |
| Ferrari Richard | Director |
Apr 16 '26 |
Buy |
0.80 |
62,500 |
50,000 |
291,636 |
| ENO Robert Paul | President |
Apr 16 '26 |
Buy |
0.80 |
12,500 |
10,000 |
36,742 |
| Ortigas-Wedekind Marga | Director |
Apr 16 '26 |
Buy |
0.80 |
25,000 |
20,000 |
137,293 |
| STROME MARK E | Director |
Apr 16 '26 |
Buy |
0.80 |
750,000 |
600,000 |
3,650,000 |
| STROME MARK E | 10% Owner |
Dec 17 '25 |
Sale |
3.58 |
250,000 |
895,000 |
2,900,000 |
| de Urioste George | Director |
Dec 18 '25 |
Sale |
2.83 |
33,185 |
93,914 |
0 |
| de Urioste George | Director |
Dec 17 '25 |
Sale |
3.68 |
23,961 |
88,176 |
33,185 |
1.79%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):